Elevated levels of the serine protease uPA, its receptor (uPAR), and inhibitor (PAI2), in tumor tissue emphasize their fundamental role in tumor invasion and metastasis and provide the rationale for this novel therapeutic strategy. The gene discussed is SERPINB2; the disease is neoplasm.